DD202169A5 - Verfahren zur herstellung von hexapyranoseverbindungen - Google Patents

Verfahren zur herstellung von hexapyranoseverbindungen Download PDF

Info

Publication number
DD202169A5
DD202169A5 DD82236918A DD23691882A DD202169A5 DD 202169 A5 DD202169 A5 DD 202169A5 DD 82236918 A DD82236918 A DD 82236918A DD 23691882 A DD23691882 A DD 23691882A DD 202169 A5 DD202169 A5 DD 202169A5
Authority
DD
German Democratic Republic
Prior art keywords
formula
radical
hydroxy
group
substituted
Prior art date
Application number
DD82236918A
Other languages
German (de)
English (en)
Inventor
Gerhard Baschang
Albert Hartmann
Oskar Wacker
Lajos Tarcsay
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of DD202169A5 publication Critical patent/DD202169A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DD82236918A 1981-01-23 1982-01-22 Verfahren zur herstellung von hexapyranoseverbindungen DD202169A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH43981 1981-01-23

Publications (1)

Publication Number Publication Date
DD202169A5 true DD202169A5 (de) 1983-08-31

Family

ID=4187055

Family Applications (1)

Application Number Title Priority Date Filing Date
DD82236918A DD202169A5 (de) 1981-01-23 1982-01-22 Verfahren zur herstellung von hexapyranoseverbindungen

Country Status (17)

Country Link
US (1) US4423038A (es)
EP (1) EP0056992A1 (es)
JP (1) JPS57142996A (es)
AU (1) AU7975182A (es)
CA (1) CA1190221A (es)
DD (1) DD202169A5 (es)
DK (1) DK28282A (es)
ES (3) ES8406502A1 (es)
FI (1) FI820178L (es)
GB (1) GB2092591B (es)
GR (1) GR78246B (es)
IE (1) IE820137L (es)
IL (1) IL64847A (es)
NO (1) NO152904C (es)
NZ (1) NZ199545A (es)
PT (1) PT74326A (es)
ZA (1) ZA82433B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5189017A (en) * 1982-07-23 1993-02-23 Ciba-Geigy Corporation Use of sugar derivatives for the prophylaxis and treatment of virus infections
EP0102319B1 (de) * 1982-07-23 1987-08-19 Ciba-Geigy Ag Verwendung von Muramylpeptiden oder deren Analogen zur Prophylaxe und Therapie von Virusinfektionen
US5334583A (en) * 1982-07-23 1994-08-02 Ciba-Geigy Corp. Use of sugar derivatives for the prophylaxis and treatment of virus infections
FI79330C (fi) * 1982-07-23 1989-12-11 Ciba Geigy Ag Foerfarande foer framstaellning av farmakologiskt verkande muramylpeptid-n-(2-fosfatidyloxietyl)-amider.
JPS5920297A (ja) * 1982-07-27 1984-02-01 Dai Ichi Seiyaku Co Ltd ムラミルジペプチド誘導体
US4933179A (en) * 1983-08-22 1990-06-12 Syntex (U.S.A.) Inc. Feline leukemia virus antigen vaccines
US4772466A (en) * 1983-08-22 1988-09-20 Syntex (U.S.A.) Inc. Vaccines comprising polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4606918A (en) * 1983-08-22 1986-08-19 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4770874A (en) * 1983-08-22 1988-09-13 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
WO1985004881A1 (en) * 1984-04-21 1985-11-07 Sandoz Ag 2,3-dinamo-2,3-didesoxyhexose derivatives, processes for their preparation and their use
FR2564096B1 (fr) * 1984-05-11 1988-02-19 Anvar Derives lipophiles de muramylpeptides ayant des proprietes d'activation des macrophages, compositions les contenant et procede pour les obtenir
DE3572491D1 (en) * 1984-07-25 1989-09-28 Ciba Geigy Ag Phosphatidyl compounds, process for their preparation and their use
US4885285A (en) * 1984-09-13 1989-12-05 Ciba-Geigy Corporation Phosphorus compounds, processes for their manufacture, and their use
US4873322A (en) * 1986-01-24 1989-10-10 Ciba-Geigy Corporation Saccharide derivatives and processes for their manufacture
US5554372A (en) * 1986-09-22 1996-09-10 Emory University Methods and vaccines comprising surface-active copolymers
US5674911A (en) * 1987-02-20 1997-10-07 Cytrx Corporation Antiinfective polyoxypropylene/polyoxyethylene copolymers and methods of use
US5811088A (en) * 1987-02-20 1998-09-22 Emory University Antiinfective compounds and methods of use
US20020123476A1 (en) * 1991-03-19 2002-09-05 Emanuele R. Martin Therapeutic delivery compositions and methods of use thereof
US7202225B1 (en) 1993-10-15 2007-04-10 Emanuele R Martin Therapeutic delivery compositions and methods of use thereof
KR100224539B1 (ko) * 1991-03-19 1999-10-15 잭 제이 루체스 개선된 생물학적 활성을 가진 폴리옥시프로필렌/폴리옥시에틸렌 공중합체 조성물
US6933286B2 (en) 1991-03-19 2005-08-23 R. Martin Emanuele Therapeutic delivery compositions and methods of use thereof
US6267968B1 (en) 1995-04-07 2001-07-31 Vacsyn S.A. MDP derivatives and conjugates having haematipoietic function stimulating activity, and compositions containing same
EP0821068A3 (en) * 1996-03-29 1999-06-02 Rohm And Haas Company Novel sphingolipids and a process thereto
AU2002302977A1 (en) * 2001-05-31 2002-12-09 Daiichi Suntory Pharma Co., Ltd. Assay method for platelet-activating factor
FR2933984B1 (fr) * 2008-07-15 2013-01-04 Univ Bourgogne D,d muramyldipeptide,composes derives et utilisation pour le traitement des plaques atheromateuses
AU2010229835B2 (en) 2009-03-25 2015-01-15 The Board Of Regents Of The University Of Texas System Compositions for stimulation of mammalian innate immune resistance to pathogens
US10286065B2 (en) 2014-09-19 2019-05-14 Board Of Regents, The University Of Texas System Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
CH613709A5 (en) * 1975-12-10 1979-10-15 Ciba Geigy Ag Process for the preparation of glucosamine derivatives
US4153684A (en) * 1976-03-10 1979-05-08 Agence Nationale De Valorisation De La Recherche (Anvar) Immunizing and anti-infectious adjuvant agents constituted by N-acetyl-muramyl-L-alanyl-D-glutamic acid derivatives
FR2369292A1 (fr) * 1976-11-02 1978-05-26 Anvar Agents adjuvants immunit
US4082735A (en) * 1976-04-26 1978-04-04 Syntex (U.S.A.) Inc. Novel immunological adjuvant compounds and methods of preparation thereof
US4082736A (en) * 1976-04-26 1978-04-04 Syntex (U.S.A.) Inc. Novel immunological adjuvant compounds and methods of preparation thereof
GB1563561A (en) * 1976-06-23 1980-03-26 Daiichi Seiyaku Co Muramyldipeptide derivatives and process for the preparation thereof
US4256735A (en) * 1979-01-29 1981-03-17 Merck & Co., Inc. Immunologically active dipeptidyl saccharides and methods of preparation
JPS5618996A (en) * 1979-06-21 1981-02-23 Dai Ichi Seiyaku Co Ltd Muramyldipeptide derivative
FI75578C (fi) * 1979-07-25 1988-07-11 Ciba Geigy Ag Analogifoerfarande foer framstaellning av farmakologiskt verkande lipofila fosfatidylmuramylpeptider.
FI803077A (fi) * 1979-10-12 1981-04-13 Ciba Geigy Ag Foerfarande foer framstaellning av myramylpeptider

Also Published As

Publication number Publication date
EP0056992A1 (de) 1982-08-04
JPS57142996A (en) 1982-09-03
ES522435A0 (es) 1985-01-01
IL64847A0 (en) 1982-03-31
IL64847A (en) 1986-02-28
GR78246B (es) 1984-09-26
GB2092591B (en) 1984-07-04
ES508944A0 (es) 1984-07-01
NO820200L (no) 1982-07-26
NO152904B (no) 1985-09-02
ZA82433B (en) 1982-12-29
ES8502446A1 (es) 1985-01-01
IE820137L (en) 1982-07-23
ES8406502A1 (es) 1984-07-01
GB2092591A (en) 1982-08-18
AU7975182A (en) 1982-07-29
ES8606370A1 (es) 1986-04-16
CA1190221A (en) 1985-07-09
US4423038A (en) 1983-12-27
FI820178L (fi) 1982-07-24
ES528142A0 (es) 1986-04-16
NO152904C (no) 1985-12-11
DK28282A (da) 1982-07-24
NZ199545A (en) 1985-07-12
PT74326A (en) 1982-02-01

Similar Documents

Publication Publication Date Title
DD202169A5 (de) Verfahren zur herstellung von hexapyranoseverbindungen
EP0027258B1 (de) Phosphorylmuramylpeptide, Verfahren zu deren Herstellung und deren Verwendung in Arzneimitteln
EP0025495B1 (de) Lipophile Muramylpeptide, Verfahren zu deren Herstellung und deren Verwendung
EP0034347B1 (de) Derivate von Aldohexosen, Zwischenprodukte, Verfahren zu ihrer Herstellung, Präparate enthaltend solche Verbindungen und ihre Verwendung
EP0114787B1 (de) Neue Peptidderivate
US4409209A (en) Novel phosphorylmuramyl peptides and processes for the manufacture thereof
EP0548024B1 (de) Aminosulfonsäurederivate und Verfahren zu ihrer Herstellung
DD217807A5 (de) Verfahren zur herstellung neuer substituierter tetrapeptide
US4548923A (en) Muramyl peptides and processes for their manufacture
US4873322A (en) Saccharide derivatives and processes for their manufacture
EP0026746B1 (de) Kombinationspräparate zur Anwendung in einem Verfahren zur Steigerung der Wirkung von Antibiotika, antibiotische Präparate mit gesteigerter Wirksamkeit und Verfahren zu deren Herstellung
AU597571B2 (en) Acylated hexose derivatives and processes for the manufacture thereof
EP0056560A1 (de) Antibiotische Präparate mit gesteigerter Wirksamkeit, Verfahren zu deren Herstellung und Verfahren zur Steigerung der antibiotischen Wirkung von Antibiotika
EP0192609A2 (de) Acylierte Hexosederivate und Verfahren zu ihrer Herstellung
KR840001687B1 (ko) 포스포릴 무라밀 펩타이드의 제조방법
EP0239543A2 (de) Neue Glucosederivate und Verfahren zu ihrer Herstellung
DD247606A5 (de) Acylierte hexosederivate und verfahren zu ihrer herstellung
EP0050703A2 (de) Neue Glucosederivate und Verfahren zu ihrer Herstellung